Provided by Tiger Fintech (Singapore) Pte. Ltd.

Femasys Inc

0.3760
-0.1391-27.00%
Pre-market: 0.37600.00000.00%04:55 EDT
Volume:12.98M
Turnover:4.34M
Market Cap:12.25M
PE:-0.44
High:0.3900
Open:0.3321
Low:0.3067
Close:0.5151
52wk High:1.80
52wk Low:0.3067
Shares:32.58M
Float Shares:27.74M
Volume Ratio:15.10
T/O Rate:46.78%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8480
EPS(LYR):-0.8450
ROE:-329.45%
ROA:-70.30%
PB:8.13
PE(LYR):-0.44

Loading ...

Femasys Inc. Faces Potential Delisting from Nasdaq Due to Noncompliance with Minimum Bid Price Requirement

Reuters
·
Jul 19

BRIEF-Femasys Files For Mixed Shelf Offering Of Up To $150 Million

Reuters
·
Jul 04

Femasys Inc. Enters Agreement to Sell Up to $10M in Shares to Alumni Capital LP

Reuters
·
Jul 04

Femasys Inc. Files Initial Statement of Beneficial Ownership for Chief Commercial Officer Nicholas Kelley Stinson

Reuters
·
Jul 02

Femasys Inc. Unveils Presentation Highlighting Innovations in Women's Reproductive Health and Strategic Focus Areas

Reuters
·
Jul 02

Femasys Gets Australia, New Zealand Approvals for Two Products

MT Newswires Live
·
Jul 01

Femasys Gains Regulatory Approvals in Australia and New Zealand

TIPRANKS
·
Jul 01

Femasys Secures Regulatory Approvals in Australia and New Zealand for Groundbreaking Infertility Solutions FemaSeed and FemVue

Reuters
·
Jul 01

Femasys Gains Momentum with EU Approval and Strategic Partnerships, Justifying Buy Rating

TIPRANKS
·
Jun 29

Femasys Approves Director Elections and Share Increase

TIPRANKS
·
Jun 26

Femasys Inc. Conducted Annual Stockholders Meeting

Reuters
·
Jun 26

Femasys Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow Jones
·
Jun 26

Strategic Growth and Market Expansion: Femasys’s European Market Positioning and CE Mark Milestone

TIPRANKS
·
Jun 25

Femasys announces milestone with European approval of FemBloc

TIPRANKS
·
Jun 25

Femasys Inc. Achieves European CE Mark Approval for FemBloc®, Pioneering Non-Surgical Permanent Birth Control Solution

Reuters
·
Jun 25

Femasys appoints Nicholas as CCO

TIPRANKS
·
Jun 17

Press Release: Femasys Names New Chief Commercial Officer to Drive Execution and Global Growth

Dow Jones
·
Jun 17

Femasys Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow Jones
·
Jun 12

Femasys: Strategic Partnerships and Revenue Growth Drive Buy Rating with $12 Price Target

TIPRANKS
·
Jun 11

Femasys Inc. Partners with Carolinas Fertility Institute to Offer Innovative FemaSeed® Treatment

Reuters
·
Jun 11